3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Lung Neoplasms
5
Carcinoma, Transitional Cell
5
Carcinoma, Hepatocellular
5
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Esophageal Neoplasms
4
Cholangiocarcinoma
4
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Neuroendocrine Tumors
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Anus Neoplasms
3
Testicular Neoplasms
2
Solid Tumor
2
Pheochromocytoma
2
Paraganglioma
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Laryngeal Neoplasms
2
Interventions
pembrolizumab
3
Nivolumab
3
Ifosfamide
3
Doxorubicin
3
AZD 6244
3
selinexor
2
pazopanib
2
fludarabine phosphate
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
tazemetostat
1
metarrestin
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Thiotepa
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Proton Therapy
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Liquid Biopsy
1
Ipilimumab
1
Injections
1
Etoposide
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
Fluorodeoxyglucose F18
×
1 year
×
Clear all
No trials found.